Details for Patent: 11,344,685

« Back to Dashboard

Which drugs does patent 11,344,685 protect, and when does it expire?

Patent 11,344,685 protects AIRDUO DIGIHALER and ARMONAIR DIGIHALER and is included in two NDAs.

Protection for AIRDUO DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-one patent family members in fourteen countries.

Summary for Patent: 11,344,685

Title:	Drug delivery device with electronics
Abstract:	A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.
Inventor(s):	Enrique Calderon Oliveras, Carl L. Lewis, Symon D'Oyly Cotton, Steven D. Gardner, Robert O. Kivlin
Assignee:	Norton Waterford Ltd
Application Number:	US15/815,758
Patent Claim Types: see list of patent claims	Use; Delivery; Device;

Drugs Protected by US Patent 11,344,685

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-004	Jul 12, 2019		DISCN	Yes	No					Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-005	Jul 12, 2019		DISCN	Yes	No					Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-006	Jul 12, 2019		DISCN	Yes	No					Y
Teva Pharm	ARMONAIR DIGIHALER	fluticasone propionate	POWDER;INHALATION	208798-008	Apr 8, 2022		DISCN	Yes	No					Y

International Family Members for US Patent 11,344,685

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017361878
Australia	2022263489
Canada	3043965
China	110167619